Search - tctmd.com

Displaying 481 - 500 of 692

Sort: Relevancy | Date

Presentation TCT 2016

Should the Sequence Be: FFR-PCI-OCT? FFR-PCI-IVUS? Just FFR or just IVUS/OCT? And When Is Angiography Enough?

Presenter: Ik-Kyung Jang, Matthew J. Price, Seung-Jung Park

October 31, 2016

Presentation TCT 2016

Cells at the Moment of Truth: Findings From Meta-analysis and Systematic Reviews

Presenter: Emerson C. Perin, Mariann Gyöngyösi

October 31, 2016

Presentation TCT 2016

Beyond Cells: Cardiac Gene Therapy In Perspective

Presenter: Emerson C. Perin, Marc S. Penn

October 31, 2016

Presentation TCT 2016

Continued Search for the Vulnerable Plaque: Are We Any Closer?

Presenter: Justin E. Davies, Ran Kornowski, Farouc Jaffer

October 31, 2016

Presentation TCT 2016

New Sights from CHART -1 at 1 Year: Relationship of outcomes to baseline biomarkers and treatment intensity

Presenter: Emerson C. Perin, Jozef Bartunek

October 31, 2016

Presentation TCT 2016

Empowering the Angiogram: Angiography-Derived FFR

Presenter: Justin E. Davies, Ran Kornowski

October 31, 2016

Presentation TCT 2016

Cells Alone Work: Lessons From Recent Clinical Trials

Presenter: Emerson C. Perin

October 31, 2016

Presentation TCT 2016

CCTA-Derived Plaque Assessment: Critical Comparison With IVUS and OCT

Presenter: Justin E. Davies, Ran Kornowski, Bon-Kwon Koo

October 31, 2016

Presentation TCT 2016

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? No, Cool Down - FFRCT Can Safely Avoid the Majority of Unnecessary Angiograms

Presenter: Justin E. Davies, Ran Kornowski, Pamela S. Douglas

October 31, 2016

Presentation TCT 2016

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? Yes For Definitive Diagnosis, and To Find and Treat Ischemia!

Presenter: Justin E. Davies, Ran Kornowski, Colin Berry

October 31, 2016

Presentation TCT 2016

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Presenter: Timothy D. Henry, Amit N. Patel, Doris A. Taylor

October 31, 2016

Presentation TCT 2016

Absolute Measurements of Microvascular Resistance by Thermodilution: First Human Data

Presenter: Javier Escaned, Amir Lerman, Bernard De Bruyne

October 31, 2016

Presentation TCT 2016

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

Presenter: Timothy D. Henry, Amit N. Patel

October 31, 2016

Presentation TCT 2016

Absolute Measurements of Microvascular Resistance by Thermodilution: Principle and Practicalities

Presenter: Javier Escaned, Amir Lerman, Nico H.J. Pijls

October 31, 2016

Presentation TCT 2016

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

Presenter: Timothy D. Henry, Amit N. Patel, Steven A.J. Chamuleau

October 31, 2016

Presentation TCT 2016

The Index of Microvascular Resistance

Presenter: Javier Escaned, Amir Lerman, William F. Fearon

October 31, 2016

Presentation TCT 2016

Clinical Importance and Metrics of the Microcirculation in Patients With Atherosclerosis

Presenter: Javier Escaned, Amir Lerman, Keith G. Oldroyd

October 31, 2016

Presentation TCT 2016

Routine FFR at the Time of Diagnostic Angiography - Ready for Primetime?

Presenter: Allen Jeremias, Nico H.J. Pijls, Nick Curzen

October 31, 2016

Presentation TCT 2016

Post-PCI FFR Measurements: Lessons From FAME I and II

Presenter: Allen Jeremias, Nico H.J. Pijls, Zsolt Piroth

October 31, 2016

Presentation TCT 2016

Contrast as a Hyperemic Agent: Easier, but Sufficient?

Presenter: Allen Jeremias, Nico H.J. Pijls, Nils Johnson

October 31, 2016

Advertisement

Should the Sequence Be: FFR-PCI-OCT? FFR-PCI-IVUS? Just FFR or just IVUS/OCT? And When Is Angiography Enough?

Cells at the Moment of Truth: Findings From Meta-analysis and Systematic Reviews

Beyond Cells: Cardiac Gene Therapy In Perspective

Continued Search for the Vulnerable Plaque: Are We Any Closer?

New Sights from CHART -1 at 1 Year: Relationship of outcomes to baseline biomarkers and treatment intensity

Empowering the Angiogram: Angiography-Derived FFR

Cells Alone Work: Lessons From Recent Clinical Trials

CCTA-Derived Plaque Assessment: Critical Comparison With IVUS and OCT

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? No, Cool Down - FFRCT Can Safely Avoid the Majority of Unnecessary Angiograms

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? Yes For Definitive Diagnosis, and To Find and Treat Ischemia!

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Absolute Measurements of Microvascular Resistance by Thermodilution: First Human Data

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

Absolute Measurements of Microvascular Resistance by Thermodilution: Principle and Practicalities

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

The Index of Microvascular Resistance

Clinical Importance and Metrics of the Microcirculation in Patients With Atherosclerosis

Routine FFR at the Time of Diagnostic Angiography - Ready for Primetime?

Post-PCI FFR Measurements: Lessons From FAME I and II

Contrast as a Hyperemic Agent: Easier, but Sufficient?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content